A group of independent advisors to the U.S. Food and Drug Administration endorsed the monoclonal antibody nirsevimab, which protects infants from respiratory syncytial virus

No comments

Read More About This Article: https://ift.tt/7YJ3EvO

No comments :

Post a Comment